Clinical trials: Tuberculosis Active

Tuberculosis

Phase 2a Study of PBTZ169

• Terminated
• Age: 18 to 65 years
• Phase 2
• Results posted

Multicenter, open, randomized study with active control (isoniazid) to evaluate the early antibacterial activity, safety and pharmacokinetics of the drug PBTZ169 (capsules 80 mg) when used in patients with first-diagnosed…

Trial name

NCT03334734

Testing

PBTZ169, Isoniazid

Volunteers

16 people

Sponsor

Nearmedic Plus LLC